Table 3.
Malaria cases | Cumulative incidence (cases/1000 population; range between shehias) | ||||
---|---|---|---|---|---|
Time period | Intervention (N = 10,944) | Control (N = 12,307) | Intervention | Control | p value |
Baseline | |||||
6 months (May–Nov 2015) | 128 | 126 | 11.7; 7.7–16.1 | 10.2; 6.4–32.8 | 0.130 |
12 months (May 2015–April 2016) | 150 | 146 | 13.7; 9.8–19.6 | 11.9; 7.5–36.8 | 0.105 |
Post-MDA | |||||
3 months (May–Aug 2016) | 31 | 41 | 2.8; 0.0–10.3 | 3.3; 0.9–8.0 | 0.721 |
6 months (May–Nov 2016)1 | 43 | 52 | 3.9; 0.0–13.1 | 4.2; 2.1–8.0 | 0.442 |
12 months (May 2016–April 2017) | 58 | 71 | 5.3; 0.0–13.1 | 5.8; 3.1–10.4 | 0.382 |
16 months (May 2016–Aug 2017) | 143 | 208 | 13.1; 5.4–28.0 | 16.9; 6.7–31.8 | 0.130 |
Post-MDA cases without travel history | |||||
3 months (May–Aug 2016) | 18 | 23 | 1.6; 0.0–9.3 | 1.9; 0.0–8.0 | 0.716 |
6 months (May–Nov 2016) | 22 | 29 | 2.0; 0.0–11.2 | 2.4; 0.9–8.0 | 0.277 |
12 months (May 2016–April 2017) | 31 | 41 | 2.8; 0.0–11.2 | 3.3; 1.1–8.0 | 0.315 |
16 months (May 2016–Aug 2017) | 109 | 160 | 10.0; 5.4–26.1 | 13.0; 2.7–30.8 | 0.279 |
1Primary outcome